Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Amwell-CLV 625 Amoxicillin & Potassium Clavulanate Tablets
Amwell-CLV 625 is a broad-spectrum antibiotic that combines Amoxicillin and Potassium Clavulanate to provide enhanced protection against bacterial infections. It is effective against various respiratory, urinary, and skin infections.
Uses of Amwell-CLV 625 Amoxicillin & Potassium Clavulanate Tablets
Respiratory tract infections (bronchitis, pneumonia, sinusitis, tonsillitis)
Urinary tract infections (UTIs)
Skin and soft tissue infections
Dental infections and otitis media
Bone and joint infections
Benefits of Amwell-CLV 625 Amoxicillin & Potassium Clavulanate Tablets
Broad-spectrum antibacterial action
Effective against beta-lactamase-producing bacteria
Fast-acting and well-tolerated
Reduces the risk of antibiotic resistance
Mechanism of Action of Amwell-CLV 625 Amoxicillin & Potassium Clavulanate Tablets
Amoxicillin inhibits bacterial cell wall synthesis, leading to bacterial death.
Potassium Clavulanate prevents bacterial resistance by inhibiting beta-lactamase enzymes.
The combination enhances antibiotic effectiveness, ensuring better treatment outcomes.